GPX1 and cancer: TXN is also another important antioxidant enzyme in normal and cancer cells.39 Increased oxidative stress due to the downregulation of GPX1 and TXN might contribute to sensitization of CD44‐KO cells to 5‐FU and sorafenib at least in part because both drugs increase oxidative stress in cells.40, 41